Is ASLN or RYLD a better dividend investment in 2026?

ASLN currently yields 333.33% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: ASLN offers higher current income.

What is the dividend yield difference between ASLN and RYLD?

ASLN has a forward dividend yield of 333.33% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 321.19 percentage points.

Home › Compare › ASLN vs RYLD

ASLN vs RYLD: Dividend Comparison 2026

ASLN yields 333.33% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ASLN wins by $3112.20M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ASLN

● Live price

333.33%

Share price

$0.60

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3112.25M

Annual income

$1,957,209,378.70

Full ASLN calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — ASLN vs RYLD

📍 ASLN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ASLN	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ASLN + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ASLN pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASLN

Annual income on $10K today (after 15% tax)

$28,333.33/yr

After 10yr DRIP, annual income (after tax)

$1,663,627,971.90/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, ASLN beats the other by $1,663,625,772.65/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASLN + RYLD for your $10,000?

ASLN: 50%RYLD: 50%

100% RYLD50/50100% ASLN

Portfolio after 10yr

$1556.15M

Annual income

$978,605,983.02/yr

Blended yield

62.89%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASLN buys

RYLD buys

No recent congressional trades found for ASLN or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricASLNRYLD

Forward yield	333.33% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$3112.25M ✓	$44.5K
Annual income after 10y	$1,957,209,378.70 ✓	$2,587.35
Total dividends collected	$3000.20M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ASLN vs RYLD ($10,000, DRIP)

Year	ASLN Portfolio	ASLN Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$44,033	$33,333.33	$11,914	$1,213.65	+$32.1K → ASLN
2	$184,291	$137,175.49	$14,099	$1,351.30	+$170.2K → ASLN
3	$733,748	$536,556.79	$16,580	$1,494.55	+$717.2K → ASLN
4	$2,781,635	$1,996,524.01	$19,384	$1,642.61	+$2.76M → ASLN
5	$10,050,002	$7,073,652.70	$22,535	$1,794.70	+$10.03M → ASLN
6	$34,638,543	$23,885,041.43	$26,063	$1,950.00	+$34.61M → ASLN
7	$114,000,322	$76,937,080.16	$29,995	$2,107.69	+$113.97M → ASLN
8	$358,625,914	$236,645,569.53	$34,361	$2,266.99	+$358.59M → ASLN
9	$1,079,474,884	$695,745,156.26	$39,194	$2,427.12	+$1079.44M → ASLN
10	$3,112,247,504	$1,957,209,378.70	$44,525	$2,587.35	+$3112.20M → ASLN

ASLN vs RYLD: Complete Analysis 2026

ASLN — Stock

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

Full ASLN Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this ASLN vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASLN vs SCHD ASLN vs JEPI ASLN vs O ASLN vs KO ASLN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.